A drug with four years of patent life remaining and MFP in effect from year two of that period is not a four-year patent estate
These mechanisms complement rather than compete, which is why many providers recommend continuing metformin when initiating semaglutide, tirzepatide, or oral alternatives like those offered through PlexusDx
Instead, it is a synthetic small molecule and has no amino-acid sequence
GLP-1 drugs: protein needs, muscle preservation, dosing strategies, evidence of broader health impacts, and more [A: 43:45, V: 45:31]
Jacobson TA, Maki KC, Orringer CE, Jones PH, Kris-Etherton P, Sikand G, et al